M Tarek Elghetany

Summary

Affiliation: University of Texas Medical Branch
Country: USA

Publications

  1. ncbi CD87 as a marker for terminal granulocytic maturation: assessment of its expression during granulopoiesis
    M Tarek Elghetany
    Division of Hematopathology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, USA
    Cytometry B Clin Cytom 51:9-13. 2003
  2. ncbi p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555 0743, USA
    Arch Pathol Lab Med 126:452-5. 2002
  3. ncbi Surface antigen changes during normal neutrophilic development: a critical review
    M Tarek Elghetany
    Division of Hematopathology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    Blood Cells Mol Dis 28:260-74. 2002
  4. ncbi Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: correlation with morphologic assessments
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    J Clin Lab Anal 18:36-41. 2004
  5. ncbi Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555 0743, USA
    Arch Pathol Lab Med 131:1110-6. 2007
  6. ncbi Physiologic variations in granulocytic surface antigen expression: impact of age, gender, pregnancy, race, and stress
    M Tarek Elghetany
    University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555 0743, USA
    J Leukoc Biol 75:157-62. 2004
  7. ncbi Impact of preanalytical variables on granulocytic surface antigen expression: a review
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    Cytometry B Clin Cytom 65:1-5. 2005
  8. ncbi The left shift: are there granulocytic surface markers that are better indicators?
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA
    Lab Hematol 10:169-71. 2004
  9. ncbi Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development
    M Tarek Elghetany
    Division of Hematopathology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA melghetautmb edu
    Am J Hematol 71:348-9. 2002
  10. ncbi Expression of CD4 on peripheral blood granulocytes. a novel finding in a case of myelodysplastic syndrome in association with t(5;12)
    M Tarek Elghetany
    Department of Pathology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, USA
    Cancer Genet Cytogenet 136:38-42. 2002

Collaborators

Detail Information

Publications17

  1. ncbi CD87 as a marker for terminal granulocytic maturation: assessment of its expression during granulopoiesis
    M Tarek Elghetany
    Division of Hematopathology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, USA
    Cytometry B Clin Cytom 51:9-13. 2003
    ..Surface expression of this antigen has not been adequately studied on bone marrow granulocytes, and the small number of previous studies has provided conflicting data...
  2. ncbi p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555 0743, USA
    Arch Pathol Lab Med 126:452-5. 2002
    ..This similarity was further investigated for p53 protein overexpression using archived tissue from patients with hematologic diseases having various leukemic propensities, including SDS and refractory anemia...
  3. ncbi Surface antigen changes during normal neutrophilic development: a critical review
    M Tarek Elghetany
    Division of Hematopathology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    Blood Cells Mol Dis 28:260-74. 2002
    ..This article reviews the alterations in surface antigen expression during normal neutrophilic granulopoiesis...
  4. ncbi Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: correlation with morphologic assessments
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    J Clin Lab Anal 18:36-41. 2004
    ..A successful strategy for detecting maturation defects is to include several antibodies that are known to be expressed or absent at the same stage of maturation, such as CD16, CD35, CD64, and CD87...
  5. ncbi Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555 0743, USA
    Arch Pathol Lab Med 131:1110-6. 2007
    ..The classification of pediatric MDSs has undergone significant evolution in the past 20 years...
  6. ncbi Physiologic variations in granulocytic surface antigen expression: impact of age, gender, pregnancy, race, and stress
    M Tarek Elghetany
    University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555 0743, USA
    J Leukoc Biol 75:157-62. 2004
    ..Stress also has an impact on some surface markers, particularly adhesion molecules, such as CD62L and CD54. These factors need to be taken in consideration for the optimal interpretation of granulocytic surface marker studies...
  7. ncbi Impact of preanalytical variables on granulocytic surface antigen expression: a review
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    Cytometry B Clin Cytom 65:1-5. 2005
    ..Despite the increased use of flow cytometry to study granulocytes, there seems to be no well-established standards regarding specimen handling for these studies...
  8. ncbi The left shift: are there granulocytic surface markers that are better indicators?
    M Tarek Elghetany
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA
    Lab Hematol 10:169-71. 2004
  9. ncbi Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development
    M Tarek Elghetany
    Division of Hematopathology, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA melghetautmb edu
    Am J Hematol 71:348-9. 2002
    ..We conclude that CD24 is expressed on the neutrophilic granulocytes at the stage of myelocytes, and hence it could potentially be used to study normal and abnormal maturation of granulocytes...
  10. ncbi Expression of CD4 on peripheral blood granulocytes. a novel finding in a case of myelodysplastic syndrome in association with t(5;12)
    M Tarek Elghetany
    Department of Pathology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, USA
    Cancer Genet Cytogenet 136:38-42. 2002
    ..Since the breakpoint on chromosome 12 is near the CD4 gene, which is mapped to 12p12, we hypothesize that dysregulation of the CD4 gene may have occurred resulting in its persistent expression on mature and maturing granulocytes...
  11. ncbi Use of error grid analysis to evaluate acceptability of a point of care prothrombin time meter
    John R Petersen
    University of Texas Medical Branch, Galveston, Texas 77555 0551, United States
    Clin Chim Acta 411:131-4. 2010
    ..We showed how error grid (EG) analysis can be used to evaluate POCT PT INR with the CL...
  12. ncbi CD36: a multiligand molecule
    Yimin Ge
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, USA
    Lab Hematol 11:31-7. 2005
    ..The future challenge will be to further understand the mechanisms by which CD36 affects these diverse functions and to design therapeutic strategies that can alter the course of the diseases...
  13. ncbi Urokinase plasminogen activator receptor (CD87): something old, something new
    Yimin Ge
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    Lab Hematol 9:67-71. 2003
    ..Therapeutic strategies targeting CD87 as a key molecule of tumor invasion and metastasis have great potential for becoming valuable assets in therapy for malignant tumors...
  14. ncbi Marginal zone variant of mantle cell lymphoma: CD5-negative cyclin D1-positive variant posing a diagnostic dilemma
    Natalia Golardi
    Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555 0743, USA
    Pathol Int 59:317-21. 2009
    ..Differentiating MCL from MZL has prognostic and therapeutic implications, particularly when considering the potential role of targeted therapy and cell cycle modulators...
  15. ncbi Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome
    M Tarek Elghetany
    Blood 99:391-2. 2002
  16. ncbi The CCC system: is it really the answer to pediatric MDS?
    Blanche P Alter
    J Pediatr Hematol Oncol 25:426-7; author reply 427-8. 2003
  17. ncbi Shwachman-Diamond syndrome: report from an international conference
    Robert Rothbaum
    St Louis Children's Hospital, St Louis, Missouri, USA
    J Pediatr 141:266-70. 2002